Literature DB >> 17641686

c-Myb regulates lineage choice in developing thymocytes via its target gene Gata3.

Diane Maurice1, Joel Hooper, Georgina Lang, Kathleen Weston.   

Abstract

During T-cell development, thymocytes with intermediate avidity for antigen-MHC complexes are positively selected and then differentiate into functional cytotoxic and helper T cells. This process is controlled by signalling from the T-cell receptor (TCR). Here, we show that the c-Myb transcription factor is a critical downstream regulator of positive selection, promoting the development of helper T cells and blocking the development of cytotoxic T cells. A gain-of-function c-Myb transgene stops development of cytotoxic T cells, instead causing accumulation of a precursor population. Conversely, loss of c-Myb in selecting cells results in significantly fewer helper T cells. In c-Myb-null thymocytes, Gata3, a critical inducer of T-helper cell fate, is not upregulated in response to T-cell receptor signaling, following selection. We show that Gata3 is a direct target of c-Myb, and propose that c-Myb is an important regulator of Gata3, required for transduction of the T-cell receptor signal for subsequent helper cell lineage differentiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17641686      PMCID: PMC1949015          DOI: 10.1038/sj.emboj.7601801

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  48 in total

Review 1.  The Ras/MAPK cascade and the control of positive selection.

Authors:  José Alberola-Ila; Gabriela Hernández-Hoyos
Journal:  Immunol Rev       Date:  2003-02       Impact factor: 12.988

2.  Evidence for distinct CD4 silencer functions at different stages of thymocyte differentiation.

Authors:  Ichiro Taniuchi; Mary Jean Sunshine; Richard Festenstein; Dan R Littman
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

Review 3.  Positive and negative selection of T cells.

Authors:  Timothy K Starr; Stephen C Jameson; Kristin A Hogquist
Journal:  Annu Rev Immunol       Date:  2002-10-16       Impact factor: 28.527

4.  Dual functions of Runx proteins for reactivating CD8 and silencing CD4 at the commitment process into CD8 thymocytes.

Authors:  Takehito Sato; Shin-ichiro Ohno; Takumi Hayashi; Chiharu Sato; Kazuyoshi Kohu; Masanobu Satake; Sonoko Habu
Journal:  Immunity       Date:  2005-03       Impact factor: 31.745

5.  Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements.

Authors:  M J Barnden; J Allison; W R Heath; F R Carbone
Journal:  Immunol Cell Biol       Date:  1998-02       Impact factor: 5.126

6.  The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment.

Authors:  Xiao He; Xi He; Vibhuti P Dave; Yi Zhang; Xiang Hua; Emmanuelle Nicolas; Weihong Xu; Bruce A Roe; Dietmar J Kappes
Journal:  Nature       Date:  2005-02-24       Impact factor: 49.962

Review 7.  Molecular genetics of T cell development.

Authors:  Ellen V Rothenberg; Tom Taghon
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

8.  c-Myb is essential for early T cell development.

Authors:  R D Allen; T P Bender; G Siu
Journal:  Genes Dev       Date:  1999-05-01       Impact factor: 11.361

9.  A dominant interfering Myb mutant causes apoptosis in T cells.

Authors:  D Taylor; P Badiani; K Weston
Journal:  Genes Dev       Date:  1996-11-01       Impact factor: 11.361

10.  T-cell lymphomas in v-Myb transgenic mice.

Authors:  P A Badiani; D Kioussis; D M Swirsky; I A Lampert; K Weston
Journal:  Oncogene       Date:  1996-11-21       Impact factor: 9.867

View more
  36 in total

1.  c-Myb, Menin, GATA-3, and MLL form a dynamic transcription complex that plays a pivotal role in human T helper type 2 cell development.

Authors:  Yuji Nakata; Anne C Brignier; Shenghao Jin; Yuan Shen; Stephen I Rudnick; Mayumi Sugita; Alan M Gewirtz
Journal:  Blood       Date:  2010-05-18       Impact factor: 22.113

Review 2.  Forging T-Lymphocyte Identity: Intersecting Networks of Transcriptional Control.

Authors:  Ellen V Rothenberg; Jonas Ungerbäck; Ameya Champhekar
Journal:  Adv Immunol       Date:  2015-10-26       Impact factor: 3.543

3.  Transfer of multiple loci of donor's genes to induce recipient tolerance in organ transplantation.

Authors:  Tong Li; Wenqian Zhang; Qing Xu; Shentao Li; Xuehong Tong; Jie Ding; Hui Li; Shengcai Hou; Zhidong Xu; David M Jablons; Liang You
Journal:  Exp Ther Med       Date:  2018-04-13       Impact factor: 2.447

4.  Architecture of a lymphomyeloid developmental switch controlled by PU.1, Notch and Gata3.

Authors:  Marissa Morales Del Real; Ellen V Rothenberg
Journal:  Development       Date:  2013-03       Impact factor: 6.868

Review 5.  The enigma of CD4-lineage specification.

Authors:  Yumei Xiong; Rémy Bosselut
Journal:  Eur J Immunol       Date:  2011-02-10       Impact factor: 5.532

6.  c-Myb and GATA-3 cooperatively regulate IL-13 expression via conserved GATA-3 response element and recruit mixed lineage leukemia (MLL) for histone modification of the IL-13 locus.

Authors:  Teruhiko Kozuka; Mayumi Sugita; Susan Shetzline; Alan M Gewirtz; Yuji Nakata
Journal:  J Immunol       Date:  2011-10-28       Impact factor: 5.422

7.  Dynamic control of the T-cell specification gene regulatory network.

Authors:  Ellen V Rothenberg
Journal:  Curr Opin Syst Biol       Date:  2019-11-06

8.  The transcription factor c-Myb primes CD4+CD8+ immature thymocytes for selection into the iNKT lineage.

Authors:  Taishan Hu; Amie Simmons; Joan Yuan; Timothy P Bender; Jose Alberola-Ila
Journal:  Nat Immunol       Date:  2010-04-11       Impact factor: 25.606

Review 9.  CD4-CD8 lineage differentiation: Thpok-ing into the nucleus.

Authors:  Lie Wang; Rémy Bosselut
Journal:  J Immunol       Date:  2009-09-01       Impact factor: 5.422

Review 10.  Linking GATA-3 and interleukin-13: implications in asthma.

Authors:  Sheikh Rayees; Fayaz Malik; Syed Imran Bukhari; Gurdarshan Singh
Journal:  Inflamm Res       Date:  2013-12-22       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.